Skip to main content
Fig. 3 | EJNMMI Research

Fig. 3

From: Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study

Fig. 3

Illustration of the pathway for 225 patients after [18F]FDG-PET/CT and biopsy/follow-up, reflecting the results of the scan and final diagnostic workup. Footnotes: Metastatic breast cancer (MBC). *Ten patients suspected of MBC were also suspected of incidental findings. A final diagnosis was not obtained due to an impossible biopsy procedure or the result of the biopsy being inconclusive

Back to article page